M
Mats Fredrikson
Researcher at Linköping University
Publications - 369
Citations - 21370
Mats Fredrikson is an academic researcher from Linköping University. The author has contributed to research in topics: Anxiety & Social anxiety. The author has an hindex of 69, co-authored 354 publications receiving 19136 citations. Previous affiliations of Mats Fredrikson include University of Pittsburgh & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health.
TL;DR: A meta-analysis of recent neuroimaging studies on the relationship between heart rate variability and regional cerebral blood flow identified a number of regions, including the amygdala and ventromedial prefrontal cortex, in which significant associations across studies were found.
Journal ArticleDOI
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
Mattias Ekstedt,Hannes Hagström,Patrik Nasr,Mats Fredrikson,Per Stål,Stergios Kechagias,Rolf Hultcrantz +6 more
TL;DR: NAFLD patients have increased risk of death, with a high risk ofdeath from cardiovascular disease and liver‐related disease, and the NAS was not able to predict overall mortality, whereas fibrosis stage predicted both overall and disease‐specific mortality.
Journal ArticleDOI
Trauma exposure and post‐traumatic stress disorder in the general population
TL;DR: The lifetime prevalence of trauma experiences and post‐traumatic stress disorder (PTSD) in men and women over a lifetime is studied to find out if these experiences are linked.
Journal ArticleDOI
Gender and age differences in the prevalence of specific fears and phobias
TL;DR: Fear of flying increased and fear of injections decreased as a function of age in women but not in men, indicating specific fears and phobias are heterogeneous with respect to sex and age distribution.
Journal ArticleDOI
Common Changes in Cerebral Blood Flow in Patients With Social Phobia Treated With Citalopram or Cognitive-Behavioral Therapy
Tomas Furmark,Maria Tillfors,Ina Marteinsdottir,Håkan Fischer,Anna Pissiota,Bengt Långström,Mats Fredrikson +6 more
TL;DR: Improvement in symptoms with citalopram and cognitive-behavioral therapy was accompanied by a decreased rCBF-response to public speaking bilaterally in the amygdala, hippocampus, and the periamygdaloid, rhinal, and parahippocampal cortices, confirmed by between-group comparisons.